Search research articles
Contact Us
Filters
Showing results (11-20 of 63) with videos related to
Page
of 7
Sort By:
Molecular Cancer Research : MCR
|
August 11, 2010
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer
Paolo Ceppi, Giridhar Mudduluru, Regalla Kumarswamy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 20, 2009
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact
Marco Volante, Ida Rapa, Manoj Gandhi, et al.
Neuroendocrinology
|
February 11, 2020
Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids
Ida Rapa, Arianna Votta, Jessica Giorcelli, et al.
European Journal of Endocrinology
|
February 11, 2014
Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features
Ilaria Messuti, Stefania Corvisieri, Francesca Bardesono, et al.
Journal of Personalized Medicine
|
June 2, 2021
Differential Expression Profiles of Cell-to-Matrix-Related Molecules in Adrenal Cortical Tumors: Diagnostic and Prognostic Implications
Marco Volante, Ida Rapa, Jasna Metovic, et al.
Human Pathology
|
February 5, 2013
Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases
Stefano La Rosa, Alessandro Marando, Gaia Gatti, et al.
Molecular and Cellular Endocrinology
|
September 11, 2013
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines
Antonina Germano, Ida Rapa, Marco Volante, et al.
Molecular and Cellular Endocrinology
|
December 16, 2014
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization
Antonina Germano, Ida Rapa, Marco Volante, et al.
The Prostate
|
May 10, 2013
Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells
Ida Rapa, Marco Volante, Cristina Migliore, et al.
Plos One
|
May 8, 2018
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells
Antonina Germano, Laura Saba, Silvia De Francia, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 63) with videos related to
Sort By:
Page
of 7
Molecular Cancer Research : MCR
|
August 11, 2010
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer
Paolo Ceppi, Giridhar Mudduluru, Regalla Kumarswamy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 20, 2009
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact
Marco Volante, Ida Rapa, Manoj Gandhi, et al.
Neuroendocrinology
|
February 11, 2020
Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids
Ida Rapa, Arianna Votta, Jessica Giorcelli, et al.
European Journal of Endocrinology
|
February 11, 2014
Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features
Ilaria Messuti, Stefania Corvisieri, Francesca Bardesono, et al.
Journal of Personalized Medicine
|
June 2, 2021
Differential Expression Profiles of Cell-to-Matrix-Related Molecules in Adrenal Cortical Tumors: Diagnostic and Prognostic Implications
Marco Volante, Ida Rapa, Jasna Metovic, et al.
Human Pathology
|
February 5, 2013
Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases
Stefano La Rosa, Alessandro Marando, Gaia Gatti, et al.
Molecular and Cellular Endocrinology
|
September 11, 2013
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines
Antonina Germano, Ida Rapa, Marco Volante, et al.
Molecular and Cellular Endocrinology
|
December 16, 2014
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization
Antonina Germano, Ida Rapa, Marco Volante, et al.
The Prostate
|
May 10, 2013
Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells
Ida Rapa, Marco Volante, Cristina Migliore, et al.
Plos One
|
May 8, 2018
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells
Antonina Germano, Laura Saba, Silvia De Francia, et al.
Page
of 7